Diabetic foot ulcers is a type of chronic wound affecting millions of patients across the globe. Diabetic foot ulcers are thickened wounds below the ankle in a diabetic patient irrespective of its duration. On account of high prevalence of diabetes, increasing geriatric population and lack of awareness on preventive measures the global diabetic foot ulcers market shows a lucrative growth between the forecast period 2022 and 2030.
The current report of diabetic foot ulcers treatment market encompasses offers essential market insights and analysis coupled with it market size, pipeline analysis and forecast estimations for the time scale, 2020-2030. This study covers a complete anatomization of the current market and provides current trends and goals of the existing market leaders.
Market share analysis and forecast estimations for the aforementioned segments are provided in terms of US$ Mn for the forecast period, 2022-2030. Furthermore, the respective growth rates for each segment has also been included. These values have been estimated keeping 2021 as its base year.
The factors that affect the growth of the diabetic foot ulcer treatment market such as market drivers, various opportunities existing within the market and market restraints have been incorporated in this study report. Company partnerships, withdrawals and pipeline molecules with target based therapy to treat diabetic foot ulcers are also one of the key inclusions of this report. The key industries holding dominance in the diabetic foot ulcers market have been identified and profiled in terms of their annual sales and growth, current market trends, key products in diabetic foot ulcer treatments, worldwide presence and generic company details. The key players of this market that have been profiled are Coloplast A/S, Medtro nic Plc., Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries, Inc., BSN Medical GMBH, Molnlycke Health Care AB, Acelity L.P. Inc., Organogenesis, Inc., 3M Healthcare, Smith & Nephew Plc., ConvaTec, Inc., Oneness Biotech Co., Ltd., Dipexium Pharmaceuticals, Inc., ViroMed Co., Ltd. & FirstString Research, Inc. A competitive landscape of the aforementioned players pertaining to their market dominance has also been presented in this report.
The diabetic foot ulcers can be characterized as neuropathic, ischemic or neuro-ischemic ulcers, depending on the etiology of the ulcer and complexity. Among the mentioned type, neuropathic ulceration remains the most common type of ulcer. However there has been massive increase in prevalence of neuro-ischemic ulcers in the recent years, accounting for 50% of the foot ulcer in 2013 as per International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Neuro-ischemic ulcers show presence of neuropathic symptoms along with gangrene wherein the onset is sudden with pain and discoloration. Owing to an advancement in diagnostic tools, development of target based medications and an extensive treatment approach in order to prevent the occurrence of gangrene, the neuro-ischemic ulcers is projected to encapsulate a larger market share in the diabetes foot ulcer treatment market in the forecast period, 2022-2030.
The preliminary goal of diabetic foot ulcer treatment is to acquire wound closure. The treatment and management of foot ulcers is solely based on the extent of severity of the ulcer and presence of infection. A multidisciplinary treatment approach is adopted thus reducing the need for amputation. The available treatment options comprises wound care dressings, bio-actives, wound care devices and antibiotic medications; bio-actives grab a larger share of the diabetic foot ulcer treatment market. Bio-actives are further segmented into growth factors, skin grafts and others. Growth- factors are globally prescribed for the treatment of diabetic foot ulcers as it promotes growth of new cells and attains wound closure, preventing the risk of infections. The increase in prevalence of diabetic foot ulcers has fueled the demand for treatment by growth-factors. Wound care dressings and wound care devices line up second in this segment due to easy availability of these treatment options, cost-effective benefits and its preliminary use for every level of severity of wound care management combined with other treatment options.
The global diabetic foot ulcers treatment market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Of the aforementioned segments, North America accounts for major share in the diabetic foot ulcers market due to increasing prevalence of diabetes, rising geriatric population, emphasis of development of break through molecules and developed healthcare infrastructure. The Medicare program in the U.S. spends more than US$ 9 billion annually on patients with diabetes-associated lower-extremity wounds, denoting availability of reimbursement policies propelling the growth of this market. Europe lines up second in this market after North America. As per The National Institute for Health and Care Excellence (NICE) the annual cost for treating diabetic foot wounds accounts to £650 million. The rise in prevalence of diabetes, developed healthcare infrastructure and availability reimbursement policies have fueled the European diabetic foot ulcers treatment market. Asia Pacific is expected to grow at a faster rate in this market in during the forecast period of 2022-2030. This growth is attributed to factors such as increasing prevalence of diabetes, development of better healthcare infrastructure and continuous efforts to maintain sustainable healthcare growth by financial inclusions.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The current report of diabetic foot ulcers treatment market encompasses offers essential market insights and analysis coupled with it market size, pipeline analysis and forecast estimations for the time scale, 2020-2030. This study covers a complete anatomization of the current market and provides current trends and goals of the existing market leaders.
Market share analysis and forecast estimations for the aforementioned segments are provided in terms of US$ Mn for the forecast period, 2022-2030. Furthermore, the respective growth rates for each segment has also been included. These values have been estimated keeping 2021 as its base year.
The factors that affect the growth of the diabetic foot ulcer treatment market such as market drivers, various opportunities existing within the market and market restraints have been incorporated in this study report. Company partnerships, withdrawals and pipeline molecules with target based therapy to treat diabetic foot ulcers are also one of the key inclusions of this report. The key industries holding dominance in the diabetic foot ulcers market have been identified and profiled in terms of their annual sales and growth, current market trends, key products in diabetic foot ulcer treatments, worldwide presence and generic company details. The key players of this market that have been profiled are Coloplast A/S, Medtro nic Plc., Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries, Inc., BSN Medical GMBH, Molnlycke Health Care AB, Acelity L.P. Inc., Organogenesis, Inc., 3M Healthcare, Smith & Nephew Plc., ConvaTec, Inc., Oneness Biotech Co., Ltd., Dipexium Pharmaceuticals, Inc., ViroMed Co., Ltd. & FirstString Research, Inc. A competitive landscape of the aforementioned players pertaining to their market dominance has also been presented in this report.
The diabetic foot ulcers can be characterized as neuropathic, ischemic or neuro-ischemic ulcers, depending on the etiology of the ulcer and complexity. Among the mentioned type, neuropathic ulceration remains the most common type of ulcer. However there has been massive increase in prevalence of neuro-ischemic ulcers in the recent years, accounting for 50% of the foot ulcer in 2013 as per International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Neuro-ischemic ulcers show presence of neuropathic symptoms along with gangrene wherein the onset is sudden with pain and discoloration. Owing to an advancement in diagnostic tools, development of target based medications and an extensive treatment approach in order to prevent the occurrence of gangrene, the neuro-ischemic ulcers is projected to encapsulate a larger market share in the diabetes foot ulcer treatment market in the forecast period, 2022-2030.
The preliminary goal of diabetic foot ulcer treatment is to acquire wound closure. The treatment and management of foot ulcers is solely based on the extent of severity of the ulcer and presence of infection. A multidisciplinary treatment approach is adopted thus reducing the need for amputation. The available treatment options comprises wound care dressings, bio-actives, wound care devices and antibiotic medications; bio-actives grab a larger share of the diabetic foot ulcer treatment market. Bio-actives are further segmented into growth factors, skin grafts and others. Growth- factors are globally prescribed for the treatment of diabetic foot ulcers as it promotes growth of new cells and attains wound closure, preventing the risk of infections. The increase in prevalence of diabetic foot ulcers has fueled the demand for treatment by growth-factors. Wound care dressings and wound care devices line up second in this segment due to easy availability of these treatment options, cost-effective benefits and its preliminary use for every level of severity of wound care management combined with other treatment options.
The global diabetic foot ulcers treatment market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Of the aforementioned segments, North America accounts for major share in the diabetic foot ulcers market due to increasing prevalence of diabetes, rising geriatric population, emphasis of development of break through molecules and developed healthcare infrastructure. The Medicare program in the U.S. spends more than US$ 9 billion annually on patients with diabetes-associated lower-extremity wounds, denoting availability of reimbursement policies propelling the growth of this market. Europe lines up second in this market after North America. As per The National Institute for Health and Care Excellence (NICE) the annual cost for treating diabetic foot wounds accounts to £650 million. The rise in prevalence of diabetes, developed healthcare infrastructure and availability reimbursement policies have fueled the European diabetic foot ulcers treatment market. Asia Pacific is expected to grow at a faster rate in this market in during the forecast period of 2022-2030. This growth is attributed to factors such as increasing prevalence of diabetes, development of better healthcare infrastructure and continuous efforts to maintain sustainable healthcare growth by financial inclusions.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Diabetic Foot Ulcers Treatment market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Diabetic Foot Ulcers Treatment market and their expected impact during the forecast period.
Market Segmentation
Ulcer
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
Treatment
- Wound Care Dressings
- Foam Dressings
- Film Dressings
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
- Bio-actives
- Growth Factors
- Skin Grafts
- Others
- Wound Care Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Antibiotics Medication
- Pipeline Analysis
- Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn)
- WH-1 Ointment
- Locilex (Pexiganan)
- VM202
- Granexin
- Tabular Representation of Phase II and I Drugs
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Diabetic Foot Ulcers Treatment market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Diabetic Foot Ulcers Treatment market?
- Which is the largest regional market for Diabetic Foot Ulcers Treatment market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Diabetic Foot Ulcers Treatment market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Diabetic Foot Ulcers Treatment market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Diabetic Foot Ulcers Treatment Market
2.2. Global Diabetic Foot Ulcers Treatment Market, By Ulcer, 2021 (US$ Million)
2.3. Global Diabetic Foot Ulcers Treatment Market, By Treatment, 2021 (US$ Million)
2.4. Global Diabetic Foot Ulcers Treatment Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021
3. Diabetic Foot Ulcers Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Diabetic Foot Ulcers Treatment Market Vendors
3.2. Strategies Adopted by Diabetic Foot Ulcers Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Diabetic Foot Ulcers Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Diabetic Foot Ulcers Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Neuropathic Ulcers
5.3.2. Ischemic Ulcers
5.3.3. Neuro-ischemic Ulcers
6. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Wound Care Dressings
6.3.1.1. Foam Dressings
6.3.1.2. Film Dressings
6.3.1.3. Hydrocolloid Dressings
6.3.1.4. Surgical Dressings
6.3.1.5. Hydrogel Dressings
6.3.2. Bio-actives
6.3.2.1. Growth Factors
6.3.2.2. Skin Grafts
6.3.2.3. Others
6.3.3. Wound Care Devices
6.3.3.1. Negative Pressure Wound Therapy
6.3.3.2. Ultrasound Therapy
6.3.4. Antibiotics Medication
6.3.5. Pipeline Analysis
6.3.5.1. Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn)
6.3.5.1.1. WH-1 Ointment
6.3.5.1.2. Locilex (Pexiganan)
6.3.5.1.3. VM202
6.3.5.1.4. Granexin
6.3.5.2. Tabular Representation of Phase II and I Drugs
7. North America Diabetic Foot Ulcers Treatment Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
7.3. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
7.4.Diabetic Foot Ulcers Treatment Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
7.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
7.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
7.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8. UK and European Union Diabetic Foot Ulcers Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.3. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.Diabetic Foot Ulcers Treatment Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.4.1.4.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.4.1.5.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
8.4.1.6.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9. Asia Pacific Diabetic Foot Ulcers Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.3. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.Diabetic Foot Ulcers Treatment Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.4.1.4.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.4.1.5.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
9.4.1.6.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
10. Latin America Diabetic Foot Ulcers Treatment Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
10.3. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
10.4.Diabetic Foot Ulcers Treatment Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
10.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
10.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
10.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
11. Middle East and Africa Diabetic Foot Ulcers Treatment Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
11.3. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
11.4.Diabetic Foot Ulcers Treatment Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
11.4.1.1.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
11.4.1.2.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Ulcer, 2020-2030, USD (Million)
11.4.1.3.1. Diabetic Foot Ulcers Treatment Market: By Treatment, 2020-2030, USD (Million)
12. Company Profile
12.1. Coloplast A/S
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Medtronic Plc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Molnlycke Health Care AB
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. B. Braun Melsungen AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Organogenesis, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Medline Industries, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. BSN Medical GMBH
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Molnlycke Health Care AB
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Acelity L.P. Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. 3M Healthcare
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Smith & Nephew Plc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. ConvaTec, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Oneness Biotech Co., Ltd.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Dipexium Pharmaceuticals, Inc.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. ViroMed Co., Ltd.
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. FirstString Research, Inc.
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
List of Figures
Figure 1 Global Diabetic Foot Ulcers Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Diabetic Foot Ulcers Treatment Market: Quality Assurance
Figure 5 Global Diabetic Foot Ulcers Treatment Market, By Ulcer, 2021
Figure 6 Global Diabetic Foot Ulcers Treatment Market, By Treatment, 2021
Figure 7 Global Diabetic Foot Ulcers Treatment Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Diabetic Foot Ulcers Treatment Market, 2021
Figure 9 Market Positioning of Key Diabetic Foot Ulcers Treatment Market Players, 2021
Figure 10 Global Diabetic Foot Ulcers Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Diabetic Foot Ulcers Treatment Market, By Ulcer, 2021 Vs 2030, %
Figure 12 Global Diabetic Foot Ulcers Treatment Market, By Treatment, 2021 Vs 2030, %
Figure 13 U.S. Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 14 Canada Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 16 UK Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 17 Germany Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 18 Spain Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 19 Italy Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 20 France Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 22 China Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 23 Japan Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 24 India Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 25 Australia Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 26 South Korea Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 28 Brazil Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 29 Mexico Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 31 GCC Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 32 Africa Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 2 Global Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 3 Global Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 4 Global Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 5 Global Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 6 Global Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 7 Global Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 8 North America Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 9 North America Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 10 North America Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 11 North America Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 12 North America Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 13 North America Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 14 North America Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 15 U.S. Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 16 U.S. Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 17 U.S. Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 18 U.S. Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 19 U.S. Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 20 U.S. Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 21 U.S. Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 22 Canada Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 23 Canada Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 24 Canada Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 25 Canada Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 26 Canada Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 27 Canada Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 28 Canada Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 29 Rest of North America Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 30 Rest of North America Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 31 Rest of North America Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 32 Rest of North America Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 33 Rest of North America Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 34 Rest of North America Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 35 Rest of North America Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 36 UK and European Union Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 37 UK and European Union Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 38 UK and European Union Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 39 UK and European Union Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 40 UK and European Union Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 41 UK and European Union Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 42 UK and European Union Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 43 UK Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 44 UK Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 45 UK Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 46 UK Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 47 UK Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 48 UK Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 49 UK Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 50 Germany Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 51 Germany Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 52 Germany Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 53 Germany Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 54 Germany Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 55 Germany Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 56 Germany Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 57 Spain Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 58 Spain Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 59 Spain Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 60 Spain Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 61 Spain Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 62 Spain Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 63 Spain Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 64 Italy Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 65 Italy Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 66 Italy Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 67 Italy Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 68 Italy Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 69 Italy Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 70 Italy Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 71 France Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 72 France Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 73 France Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 74 France Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 75 France Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 76 France Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 77 France Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 78 Rest of Europe Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 79 Rest of Europe Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 80 Rest of Europe Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 81 Rest of Europe Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 82 Rest of Europe Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 83 Rest of Europe Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 84 Rest of Europe Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 85 Asia Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 86 Asia Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 87 Asia Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 88 Asia Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 89 Asia Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 90 Asia Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 91 Asia Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 92 China Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 93 China Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 94 China Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 95 China Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 96 China Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 97 China Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 98 China Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 99 Japan Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 100 Japan Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 101 Japan Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 102 Japan Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 103 Japan Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 104 Japan Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 105 Japan Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 106 India Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 107 India Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 108 India Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 109 India Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 110 India Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 111 India Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 112 India Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 113 Australia Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 114 Australia Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 115 Australia Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 116 Australia Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 117 Australia Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 118 Australia Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 119 Australia Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 120 South Korea Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 121 South Korea Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 122 South Korea Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 123 South Korea Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 124 South Korea Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 125 South Korea Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 126 South Korea Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 127 Latin America Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 128 Latin America Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 129 Latin America Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 130 Latin America Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 131 Latin America Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 132 Latin America Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 133 Latin America Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 134 Brazil Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 135 Brazil Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 136 Brazil Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 137 Brazil Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 138 Brazil Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 139 Brazil Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 140 Brazil Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 141 Mexico Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 142 Mexico Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 143 Mexico Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 144 Mexico Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 145 Mexico Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 146 Mexico Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 147 Mexico Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 148 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 149 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 150 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 151 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 152 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 153 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 154 Rest of Latin America Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 155 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 156 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 157 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 158 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 159 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 160 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 161 Middle East and Africa Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 162 GCC Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 163 GCC Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 164 GCC Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 165 GCC Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 166 GCC Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 167 GCC Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 168 GCC Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 169 Africa Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 170 Africa Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 171 Africa Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 172 Africa Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 173 Africa Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 174 Africa Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 175 Africa Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Table 176 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Ulcer, 2020-2030, USD (Million)
Table 177 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Treatment, 2020-2030, USD (Million)
Table 178 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Wound Care Dressings, 2020-2030, USD (Million)
Table 179 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Bio-actives, 2020-2030, USD (Million)
Table 180 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Wound Care Devices, 2020-2030, USD (Million)
Table 181 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 182 Rest of Middle East and Africa Diabetic Foot Ulcers Treatment Market By Projected sales of Phase III Drugs Estimated till 2029 (US$ Mn), 2020-2030, USD (Million)
Companies Mentioned
- Coloplast A/S
- Medtro nic Plc.
- Molnlycke Health Care AB
- B. Braun Melsungen AG
- Medline Industries Inc.
- BSN Medical GMBH
- Molnlycke Health Care AB
- Acelity L.P. Inc.
- Organogenesis Inc.
- 3M Healthcare
- Smith & Nephew Plc.
- ConvaTec Inc.
- Oneness Biotech Co. Ltd.
- Dipexium Pharmaceuticals Inc.
- ViroMed Co. Ltd.
- FirstString Research Inc.
